Position Papers:
|
|
5th February, 2012:
|
Comments from the European Industrial Pharmacists Group on the Commission’s Concept Paper on the Revision of Annex 16.
|
|
31st December, 2011:
|
Comments from the European Industrial Pharmacists Group on the Commission’s Revised Guidelines on Good Distribution Practice of Medicinal Products for Human Use.
|
|
14th September, 2011:
|
EIPG Response to the Green Paper on Modernising the Professional Qualifications Directive.
|
|
28th April, 2011:
|
EIPG Comments on 'Template for the Qualified Person’s declaration concerning GMP compliance of the active substance used as starting material and verification of its supply chain “The QP declaration template”' (EMA/CHMP/CVMP/QWP/696270/2010).
|
|
15th March, 2011:
|
EIPG response to the Consultation on Professional Qualifications Directive.
|
|
26th February, 2011:
|
EIPG Consolidated Responses to Concept Papers on Storage Conditions During Transport and GMP Chapter 6, and proposed revisions of GMP Chapter 5 and GMP Chapter 7.
|
|
30th July, 2010:
|
EIPG Consolidated Response to proposed changes to GMP Chapters 1 and 2.
|
|
4th October, 2009:
|
Comments from the European Industrial Pharmacists Group on the European Commission Proposals for the Provision of Information to Patients on Prescription Medicines
|
|
27th October, 2008:
|
EIPG Response to Consultation on Annex 13
|
|
2nd June, 2008:
|
Concept Paper on a Guideline on Chemical and Pharmaceutical Quality Documentation concerning Biological Investigational Medicinal Products in Clinical Trials
|
|
7th May, 2008:
|
Contribution from Groupement des Pharmaciens de L’Industrie en Europe (European Industrial Pharmacists’ Group), to the Public Consultation in Preparation of a legal proposal to combat Counterfeit Medicines for Human Use
|
|
19th June, 2007:
|
The Responsible Person and Wholesale Supply in the UK
|
|